AU2001235976A1 - An antidiabetic composition of amino acids - Google Patents

An antidiabetic composition of amino acids

Info

Publication number
AU2001235976A1
AU2001235976A1 AU2001235976A AU3597601A AU2001235976A1 AU 2001235976 A1 AU2001235976 A1 AU 2001235976A1 AU 2001235976 A AU2001235976 A AU 2001235976A AU 3597601 A AU3597601 A AU 3597601A AU 2001235976 A1 AU2001235976 A1 AU 2001235976A1
Authority
AU
Australia
Prior art keywords
amino acids
antidiabetic composition
antidiabetic
composition
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235976A
Other languages
English (en)
Inventor
Malladi Surya Prakasa Sastry
Rajagopal Thiruvengadam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001235976A1 publication Critical patent/AU2001235976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001235976A 2000-12-19 2000-12-19 An antidiabetic composition of amino acids Abandoned AU2001235976A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000128 WO2002049636A1 (fr) 2000-12-19 2000-12-19 Composition antidiabetique a base d'aminoacides

Publications (1)

Publication Number Publication Date
AU2001235976A1 true AU2001235976A1 (en) 2002-07-01

Family

ID=11076292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235976A Abandoned AU2001235976A1 (en) 2000-12-19 2000-12-19 An antidiabetic composition of amino acids

Country Status (2)

Country Link
AU (1) AU2001235976A1 (fr)
WO (1) WO2002049636A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005110394A1 (ja) * 2004-05-19 2008-03-21 味の素株式会社 糖尿病治療薬
CN101106914B (zh) * 2005-01-18 2012-12-26 帝斯曼知识产权资产管理有限公司 营养药物性组合物
JP2008247856A (ja) * 2007-03-30 2008-10-16 Ajinomoto Co Inc Ａｍｐｋ活性化剤
US20110237670A1 (en) * 2008-12-12 2011-09-29 Daniel Klamer Improvement of normal cognitive function
AU2014277952A1 (en) * 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
AU2014333977B2 (en) 2013-10-09 2019-12-19 Société des Produits Nestlé S.A. Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
US11224582B2 (en) 2017-04-25 2022-01-18 Almeda Labs Llc Amino acid formulations for pancreatic viability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
JPS60255722A (ja) * 1984-05-30 1985-12-17 Otsuka Pharmaceut Factory Inc 糖尿病用アミノ酸輸液
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.

Also Published As

Publication number Publication date
WO2002049636A1 (fr) 2002-06-27

Similar Documents

Publication Publication Date Title
HUP0300299A3 (en) Composition comprising free amino acids
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
AU2002239262A1 (en) Compositions of peptide crystals
AU2001241128A1 (en) Novel amide compounds
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001282301A1 (en) Fuel composition
AU2001252638A1 (en) Process for the preparation of 2-halobenzoic acids
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002224884A1 (en) Substituted anthranilic acids
AU3326999A (en) An acidic cleaning composition comprising an acidic protease
AU2001273761A1 (en) Preparation of (r)-2-alkyl-3-phenylpropionic acids
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001284418A1 (en) Novel polypeptide
AU2001235976A1 (en) An antidiabetic composition of amino acids
AU2002234171A1 (en) Detection of modified amino acids by mass spectrometry
AU2002224060A1 (en) Novel fructosyl amino acid oxidase
AU2001280176A1 (en) Novel ester or amide derivatives
AU2001280223A1 (en) Fusion protein containing additional cationic amino acids and improvement of bio-operation by using same
AU2001258543A1 (en) Branched amino acids
AUPQ906400A0 (en) Molluscicidal composition
AU5676101A (en) Fuel composition
AU2003245571A1 (en) Preparation of protected amino acids